These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23106100)

  • 1. Suppression of pain-related behavior in two distinct rodent models of peripheral neuropathy by a homopolyarginine-conjugated CRMP2 peptide.
    Ju W; Li Q; Allette YM; Ripsch MS; White FA; Khanna R
    J Neurochem; 2013 Mar; 124(6):869-79. PubMed ID: 23106100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2.2 trafficking and reverses inflammatory and postoperative pain behaviors.
    François-Moutal L; Wang Y; Moutal A; Cottier KE; Melemedjian OK; Yang X; Wang Y; Ju W; Largent-Milnes TM; Khanna M; Vanderah TW; Khanna R
    Pain; 2015 Jul; 156(7):1247-1264. PubMed ID: 25782368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRMP-2 peptide mediated decrease of high and low voltage-activated calcium channels, attenuation of nociceptor excitability, and anti-nociception in a model of AIDS therapy-induced painful peripheral neuropathy.
    Piekarz AD; Due MR; Khanna M; Wang B; Ripsch MS; Wang R; Meroueh SO; Vasko MR; White FA; Khanna R
    Mol Pain; 2012 Jul; 8():54. PubMed ID: 22828369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained relief of ongoing experimental neuropathic pain by a CRMP2 peptide aptamer with low abuse potential.
    Xie JY; Chew LA; Yang X; Wang Y; Qu C; Wang Y; Federici LM; Fitz SD; Ripsch MS; Due MR; Moutal A; Khanna M; White FA; Vanderah TW; Johnson PL; Porreca F; Khanna R
    Pain; 2016 Sep; 157(9):2124-2140. PubMed ID: 27537210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenging the catechism of therapeutics for chronic neuropathic pain: Targeting CaV2.2 interactions with CRMP2 peptides.
    Feldman P; Khanna R
    Neurosci Lett; 2013 Dec; 557 Pt A(0 0):27-36. PubMed ID: 23831344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of transmitter release and attenuation of anti-retroviral-associated and tibial nerve injury-related painful peripheral neuropathy by novel synthetic Ca2+ channel peptides.
    Wilson SM; Schmutzler BS; Brittain JM; Dustrude ET; Ripsch MS; Pellman JJ; Yeum TS; Hurley JH; Hingtgen CM; White FA; Khanna R
    J Biol Chem; 2012 Oct; 287(42):35065-35077. PubMed ID: 22891239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting the role of the CRMP2-neurofibromin complex on pain behaviors.
    Moutal A; Wang Y; Yang X; Ji Y; Luo S; Dorame A; Bellampalli SS; Chew LA; Cai S; Dustrude ET; Keener JE; Marty MT; Vanderah TW; Khanna R
    Pain; 2017 Nov; 158(11):2203-2221. PubMed ID: 28767512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the Ubc9 E2 SUMO-conjugating enzyme-CRMP2 interaction decreases NaV1.7 currents and reverses experimental neuropathic pain.
    François-Moutal L; Dustrude ET; Wang Y; Brustovetsky T; Dorame A; Ju W; Moutal A; Perez-Miller S; Brustovetsky N; Gokhale V; Khanna M; Khanna R
    Pain; 2018 Oct; 159(10):2115-2127. PubMed ID: 29847471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further insights into the antinociceptive potential of a peptide disrupting the N-type calcium channel-CRMP-2 signaling complex.
    Wilson SM; Brittain JM; Piekarz AD; Ballard CJ; Ripsch MS; Cummins TR; Hurley JH; Khanna M; Hammes NM; Samuels BC; White FA; Khanna R
    Channels (Austin); 2011; 5(5):449-56. PubMed ID: 21829088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (S)-lacosamide inhibition of CRMP2 phosphorylation reduces postoperative and neuropathic pain behaviors through distinct classes of sensory neurons identified by constellation pharmacology.
    Moutal A; Chew LA; Yang X; Wang Y; Yeon SK; Telemi E; Meroueh S; Park KD; Shrinivasan R; Gilbraith KB; Qu C; Xie JY; Patwardhan A; Vanderah TW; Khanna M; Porreca F; Khanna R
    Pain; 2016 Jul; 157(7):1448-1463. PubMed ID: 26967696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRMP2-derived peptide ST2-104 (R9-CBD3) protects SH-SY5Y neuroblastoma cells against Aβ
    Ji Y; Hu Y; Ren J; Khanna R; Yao Y; Chen Y; Li Q; Sun L
    Chem Biol Interact; 2019 May; 305():28-39. PubMed ID: 30871964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic CRMP2 Regulation of CaV2.2 in the Prefrontal Cortex Contributes to the Reinstatement of Cocaine Seeking.
    Buchta WC; Moutal A; Hines B; Garcia-Keller C; Smith ACW; Kalivas P; Khanna R; Riegel AC
    Mol Neurobiol; 2020 Jan; 57(1):346-357. PubMed ID: 31359322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homology-guided mutational analysis reveals the functional requirements for antinociceptive specificity of collapsin response mediator protein 2-derived peptides.
    Moutal A; Li W; Wang Y; Ju W; Luo S; Cai S; François-Moutal L; Perez-Miller S; Hu J; Dustrude ET; Vanderah TW; Gokhale V; Khanna M; Khanna R
    Br J Pharmacol; 2018 Jun; 175(12):2244-2260. PubMed ID: 28161890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRMP2-Neurofibromin Interface Drives NF1-related Pain.
    Moutal A; Sun L; Yang X; Li W; Cai S; Luo S; Khanna R
    Neuroscience; 2018 Jun; 381():79-90. PubMed ID: 29655575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylated CRMP2 Regulates Spinal Nociceptive Neurotransmission.
    Yu J; Moutal A; Dorame A; Bellampalli SS; Chefdeville A; Kanazawa I; Pham NYN; Park KD; Weimer JM; Khanna R
    Mol Neurobiol; 2019 Jul; 56(7):5241-5255. PubMed ID: 30565051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AAV-encoded Ca
    Yu H; Shin SM; Xiang H; Chao D; Cai Y; Xu H; Khanna R; Pan B; Hogan QH
    Gene Ther; 2019 Aug; 26(7-8):308-323. PubMed ID: 31118475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A peptidomimetic modulator of the Ca
    Gomez K; Santiago U; Nelson TS; Allen HN; Calderon-Rivera A; Hestehave S; Rodríguez Palma EJ; Zhou Y; Duran P; Loya-Lopez S; Zhu E; Kumar U; Shields R; Koseli E; McKiver B; Giuvelis D; Zuo W; Inyang KE; Dorame A; Chefdeville A; Ran D; Perez-Miller S; Lu Y; Liu X; Handoko ; Arora PS; Patek M; Moutal A; Khanna M; Hu H; Laumet G; King T; Wang J; Damaj MI; Korczeniewska OA; Camacho CJ; Khanna R
    Proc Natl Acad Sci U S A; 2023 Nov; 120(47):e2305215120. PubMed ID: 37972067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of T-type calcium channels is independent of CRMP2 in sensory neurons.
    Cai S; Shan Z; Zhang Z; Moutal A; Khanna R
    Channels (Austin); 2019 Dec; 13(1):147-152. PubMed ID: 31025580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMOylation alters CRMP2 regulation of calcium influx in sensory neurons.
    Ju W; Li Q; Wilson SM; Brittain JM; Meroueh L; Khanna R
    Channels (Austin); 2013; 7(3):153-9. PubMed ID: 23510938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical shift perturbation mapping of the Ubc9-CRMP2 interface identifies a pocket in CRMP2 amenable for allosteric modulation of Nav1.7 channels.
    François-Moutal L; Scott DD; Perez-Miller S; Gokhale V; Khanna M; Khanna R
    Channels (Austin); 2018; 12(1):219-227. PubMed ID: 30081699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.